We are live on
!
Find out more
Regenxbio
RGNX
RGNX
174 hedge funds and large institutions have $593M invested in Regenxbio in 2025 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 62 increasing their positions, 60 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
71% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 14
49% more capital invested
Capital invested by funds: $399M → $593M (+$194M)
5% more funds holding
Funds holding: 166 → 174 (+8)
8% more call options, than puts
Call options by funds: $2.83M | Put options by funds: $2.62M
3% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 60
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.6% less ownership
Funds ownership: 81.88% → 81.28% (-0.6%)
Holders
174
Holders Change
+8
Holders Change %
+4.82%
% of All Funds
2.12%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
62
Reduced
60
Closed
14
Calls
$2.83M
Puts
$2.62M
Net Calls
+$212K
Net Calls Change
+$332K
Top Buyers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.67M |
| 2 |
Morgan Stanley
New York
|
+$3.87M |
| 3 |
State Street
Boston,
Massachusetts
|
+$3.76M |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$3.04M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.97M |
Top Sellers
| 1 |
BlackRock
New York
|
-$7.65M |
| 2 |
JP Morgan Chase
New York
|
-$6.03M |
| 3 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$4.12M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$4.05M |
| 5 |
VC
Voss Capital
Houston,
Texas
|
-$2.56M |
